APA

Freyer G., Kalinka-Warzocha E., Syrigos K., Marinca M., Tonini G., Ng S. L., Wong Z. W., Salar A., Steger G., Abdelsalam M., DeCosta L. & Szabo Z. (20160608). Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia. : Medical oncology (Northwood, London, England).

Chicago

Freyer Gilles, Kalinka-Warzocha Ewa, Syrigos Konstantinos, Marinca Mihai, Tonini Giuseppe, Ng Say Liang, Wong Zee Wan, Salar Antonio, Steger Guenther, Abdelsalam Mahmoud, DeCosta Lucy and Szabo Zsolt. 20160608. Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia. : Medical oncology (Northwood, London, England).

Harvard

Freyer G., Kalinka-Warzocha E., Syrigos K., Marinca M., Tonini G., Ng S. L., Wong Z. W., Salar A., Steger G., Abdelsalam M., DeCosta L. and Szabo Z. (20160608). Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia. : Medical oncology (Northwood, London, England).

MLA

Freyer Gilles, Kalinka-Warzocha Ewa, Syrigos Konstantinos, Marinca Mihai, Tonini Giuseppe, Ng Say Liang, Wong Zee Wan, Salar Antonio, Steger Guenther, Abdelsalam Mahmoud, DeCosta Lucy and Szabo Zsolt. Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia. : Medical oncology (Northwood, London, England). 20160608.